Comparison of breast cancer in young and old women based on clinicopathological features;A fiatal-és idoskori emlorák összehasonlí tása klinikopatológiai jellemzok alapján

Magyar Onkologia

Volumn 54, Issue 1, 2010, Pages 19-26

  Székely, Borbála ^a   Madaras, Lilla ^a   Szentmártoni, Gyöngyvér ^a   Szász, A Marcell ^a   Baranyák, Zsuzsanna ^a   Szittya, Liliána ^a   Torgyík, László ^a   Zergényi, Éva ^a   Borbényi, Erika ^a   Kenessey, István ^a   Korompay, Anna ^a   Langmár, Zoltán ^a   Bánhidy, Ferenc ^a   Kulka, Janina ^a   Dank, Magdolna ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Breast cancer; Elderly; Prognosis; Survival; Young

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EDUCATION PROGRAM; FAMILY HISTORY; FEMALE; HISTOLOGY; HUMAN; HUNGARY; IMMUNOPHENOTYPING; MENSTRUATION; ONSET AGE; OVERALL SURVIVAL; PREDICTOR VARIABLE; PROGNOSIS; REPRODUCTION; SELF EXAMINATION; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENES, BRCA1; GENES, BRCA2; GENES, TUMOR SUPPRESSOR; HUMANS; HUNGARY; LYMPHATIC METASTASIS; MUTATION; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCTION; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950275697     PISSN: 00250244     EISSN: None     Source Type: Journal    
DOI: 10.1556/MOnkol.54.2010.1.3     Document Type: Article

References (26)

1. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360:187-195, 2002
2. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358:1389-1399, 2001
3. Albrektsen G, Heuch I, Thoresen S, Kvale G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev 15:65-69, 2006
4. Boer K. Idskori emldaganatok kezelésének lehetségei. Orvosi Hetilap 146:15-21, 2005
5. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808, 2005
6. Dawson PJ, Ferguson DJ, Karrison T. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy. Cancer 50:2131-2138, 1982
7. De Castillo B, Cawthorn S, Moppett J, et al. Expression of prolactin receptor mRNA in oestrogen receptor positive breast cancers preand post-tamoxifen therapy. Eur J Surg Oncol 30:515-519, 2004
8. El Saghir NS, Seoud M, Khalil MK, et al. Effects of young age at presentation on survival in breast cancer. BMC Cancer 6:194, 2006
9. Ellis IO, Galea M, Broughton N, et al. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479-489, 1992
10. Han W, Kang SY. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 2009
11. Kim JK, Kwak BS, Lee JS, et al. Do very young Korean breast cancer patients have worse outcomes? Ann Surg Oncol 14:3385-3391, 2007
12. Klauber-DeMore N. Tumor biology of breast cancer in young women. Breast Dis 23:9-15, 2005
13. Koscielny S, Tubiana M, Le MG, et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709-715, 1984
14. Kothari AS, Beechey-Newman N, D'Arrigo C, et al. Breast carcinoma in women age 25 years or less. Cancer 94:606-614, 2002
15. Kulka J, Tkés AM, Tóth AI, et al. Az emldaganatok primer szisztémás kemoterápiára adott válasza az immunhisztokémiai fenotípus tükrében. Magyar Onkológia 53:335-343, 2009
16. Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 8:R43, 2006
17. Macmillan RD, Purushotham AD, Mallon E, et al. Breast-conserving surgery and tumour bed positivity in patients with breast cancer. Br J Surg 81:56-58, 1994
18. McCormack VA, Dos Santos Silva I. Breast density and parenchymal patt erns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159-1169, 2006
19. Olivier M, Langerod A, Carrieri P, et al. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res 12:1157-1167, 2006
20. Paillocher N, Lacourtoisie SA, Fondrinier E, et al. [Infiltrating breast cancer in women younger than 25 years: 13 cases]. Presse Med 35:1618-1624, 2006
21. Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology 52:108-118, 2008
22. Suen D, Chow LW. Prognostic contribution of the HER-2 oncogene overexpression to the Nott ingham Prognostic Index in breast cancer. Biomed Pharmacother 60:293-297, 2006
23. Terry KL, Willett WC, Rich-Edwards JW, et al. Menstrual cycle characteristics and incidence of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14:1509-1513, 2005
24. Veronesi U, Luini A, Galimberti V, Zurrida S. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 18:70-75, 1994
25. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
26. Wood PA, Hrushesky WJ. Sex cycle modulates cancer growth. Breast Cancer Res Treat 91:95-102, 2005